Literature DB >> 32976935

Antibiotic use and reduced effectiveness of second-line immunotherapy for lung cancer: all the time or just at the start of treatment?

E M W van de Garde1, L R van Bedaf2, D P Hurkmans3, M M van den Heuvel4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32976935     DOI： 10.1016/j.annonc.2020.09.007

Source DB:  PubMed          Journal:  Ann Oncol        ISSN： 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  2 in total

1.  The association between gut microbiome affecting concomitant medication and the effectiveness of immunotherapy in patients with stage IV NSCLC.

Authors:  M V Verschueren; C M Cramer- van der Welle; M Tonn; F M N H Schramel; B J M Peters; E M W van de Garde
Journal:  Sci Rep       Date:  2021-12-02       Impact factor: 4.379

Review 2.  A new biological triangle in cancer: intestinal microbiota, immune checkpoint inhibitors and antibiotics.

Authors:  Jie Zhang; Zhujiang Dai; Cheng Yan; Wenjie Zhang; Daorong Wang; Dong Tang
Journal:  Clin Transl Oncol       Date:  2021-06-14       Impact factor: 3.405
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.